AR062644A1 - Tecnologia de suministro programable flotante - Google Patents
Tecnologia de suministro programable flotanteInfo
- Publication number
- AR062644A1 AR062644A1 ARP070103903A ARP070103903A AR062644A1 AR 062644 A1 AR062644 A1 AR 062644A1 AR P070103903 A ARP070103903 A AR P070103903A AR P070103903 A ARP070103903 A AR P070103903A AR 062644 A1 AR062644 A1 AR 062644A1
- Authority
- AR
- Argentina
- Prior art keywords
- programmable supply
- supply technology
- core
- relates
- floating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
Abstract
La presente invencion se relaciona con un sistema para el suministro espacial y temporalmente programable de un agente activo. Cuando se suministra por vía oral, el sistema puede ser retenido en la region gástrica por un período prolongado. El sistema comprende un nucleo, una o más capas recubiertas sobre el nucleo y un espacio hueco pre-formado. La invencion también se refiere a un proceso para la preparacion del sistema y un método para tratar/prevenir enfermedades mediante el suministro del sistema de la invencion a un sujeto que lo necesita.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN1411MU2006 | 2006-09-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR062644A1 true AR062644A1 (es) | 2008-11-19 |
Family
ID=39430167
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070103903A AR062644A1 (es) | 2006-09-04 | 2007-09-04 | Tecnologia de suministro programable flotante |
Country Status (16)
Country | Link |
---|---|
US (1) | US8277843B2 (es) |
EP (1) | EP2068844A4 (es) |
JP (1) | JP2010502591A (es) |
KR (1) | KR20090065524A (es) |
CN (1) | CN101511346B (es) |
AR (1) | AR062644A1 (es) |
AU (1) | AU2007323018B2 (es) |
BR (1) | BRPI0716481A2 (es) |
CA (1) | CA2661172A1 (es) |
CL (1) | CL2007002562A1 (es) |
IL (1) | IL197121A0 (es) |
MX (1) | MX2009002371A (es) |
NO (1) | NO20090807A (es) |
RU (1) | RU2420268C2 (es) |
WO (1) | WO2008062440A2 (es) |
ZA (1) | ZA200901162B (es) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7201920B2 (en) | 2003-11-26 | 2007-04-10 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse of opioid containing dosage forms |
WO2009153635A1 (en) * | 2008-06-19 | 2009-12-23 | University Of Witwatersrand, Johannesburg | A chronotherapeutic pharmaceutical dosage form |
ZA200903858B (en) * | 2008-06-19 | 2013-10-30 | Univ Of Witwatesrand Johannesburg | Pharmaceutical dosage form |
CA2638240C (en) * | 2008-08-29 | 2010-02-02 | Alexander Macgregor | Method of treating dysglycemia and glucose excursions |
EP2457561A4 (en) * | 2009-07-06 | 2014-03-05 | Kyorin Seiyaku Kk | TABLET HAVING A HOLLOW STRUCTURE |
US8901113B2 (en) | 2009-09-30 | 2014-12-02 | Acura Pharmaceuticals, Inc. | Methods and compositions for deterring abuse |
US20110177231A1 (en) * | 2010-01-16 | 2011-07-21 | Alexander Grinberg | Nano-, Micro-, Macro- Encapsulation And Release Of Materials |
US20110200671A1 (en) * | 2010-02-17 | 2011-08-18 | Sun Pharma Advanced Research Company Ltd. | Method of treating a disease condition susceptible to baclofen therapy |
EP2415460A1 (de) * | 2010-08-03 | 2012-02-08 | ratiopharm GmbH | Orale Darreichungsform von Pregabalin |
GB201102148D0 (en) * | 2011-02-08 | 2011-03-23 | Ucl Business Plc | Layered bodies, compositions containing them and processes for producing them |
EP2731609A1 (en) * | 2011-07-14 | 2014-05-21 | APeT Holding B.V. | Nicotinamide compositions and the therapeutic use thereof |
EP3446685A1 (en) | 2012-11-30 | 2019-02-27 | Acura Pharmaceuticals, Inc. | Self-regulated release of active pharmaceutical ingredient |
US8859005B2 (en) | 2012-12-03 | 2014-10-14 | Intercontinental Great Brands Llc | Enteric delivery of functional ingredients suitable for hot comestible applications |
KR102241487B1 (ko) | 2013-02-20 | 2021-04-16 | 주식회사 종근당 | 제어방출 펠릿으로 된 약제학적 조성물 |
JP2016533864A (ja) * | 2013-10-22 | 2016-11-04 | キャプソ・ヴィジョン・インコーポレーテッド | マルチ密度相を有するカプセル装置に用いられるシステム及び方法 |
CA2943728C (en) | 2014-03-26 | 2020-03-24 | Sun Pharma Advanced Research Company Ltd. | Abuse deterrent immediate release biphasic matrix solid dosage form |
AU2015274453A1 (en) | 2014-06-11 | 2017-01-12 | Massachusetts Institute Of Technology | Enteric elastomers |
US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
US11103581B2 (en) | 2015-08-31 | 2021-08-31 | Acura Pharmaceuticals, Inc. | Methods and compositions for self-regulated release of active pharmaceutical ingredient |
US11576859B2 (en) | 2015-10-23 | 2023-02-14 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
EP3518902A4 (en) | 2016-09-30 | 2020-07-08 | Lyndra, Inc. | STOMACH RESTORATION SYSTEMS FOR RETARD RELEASE OF ACTIVE SUBSTANCES |
US11534404B2 (en) * | 2016-10-06 | 2022-12-27 | Sucampo Ag | Multilayer beads for pharmaceutical use |
WO2019025869A1 (en) * | 2017-07-31 | 2019-02-07 | Teva Pharmaceutical Industries Limited | GALENIC FORMS WITH CONTROLLED RELEASE MANUFACTURED IN ADDITIVE MANNER |
US11337920B2 (en) | 2017-12-18 | 2022-05-24 | Tris Pharma, Inc. | Pharmaceutical composition comprising GHB gastro-retentive raft forming systems having trigger pulse drug release |
US11666546B2 (en) | 2017-12-18 | 2023-06-06 | Tris Pharma, Inc | GHB pharmaceutical compositions comprising a floating interpenetrating polymer network forming system |
WO2019126218A1 (en) | 2017-12-18 | 2019-06-27 | Tris Pharma, Inc. | Modified release drug powder composition comprising gastro-retentive raft forming systems having trigger pulse drug release |
JP7000148B2 (ja) * | 2017-12-27 | 2022-01-19 | 日本化薬株式会社 | ダサチニブを有効成分とする医薬組成物 |
JP2022544239A (ja) * | 2019-08-12 | 2022-10-17 | マサチューセッツ インスティテュート オブ テクノロジー | 治療薬の投与のための物品及び方法 |
TWI763036B (zh) * | 2020-09-14 | 2022-05-01 | 王子賓 | 可膨脹微膠囊 |
AU2022241157A1 (en) | 2021-03-15 | 2023-09-07 | Epitomee Medical Ltd. | Expandable devices for delivery of active agents to tissues |
WO2024062466A1 (en) | 2022-09-21 | 2024-03-28 | Epitomee Medical Ltd. | Controllably disintegrable self-expandable ingestible devices |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5512411B2 (es) * | 1974-03-12 | 1980-04-02 | ||
JPS5134879A (en) * | 1974-09-19 | 1976-03-24 | Eisai Co Ltd | Bishochukuryushinoseizoho |
US5002772A (en) * | 1988-05-31 | 1991-03-26 | Pfizer Inc. | Gastric retention system for controlled drug release |
NZ233403A (en) * | 1989-04-28 | 1992-09-25 | Mcneil Ppc Inc | Simulated capsule-like medicament |
JPH03101615A (ja) * | 1989-09-14 | 1991-04-26 | Sumitomo Pharmaceut Co Ltd | 胃内滞留型持続性製剤 |
IT1246382B (it) * | 1990-04-17 | 1994-11-18 | Eurand Int | Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon |
US5314696A (en) * | 1991-06-27 | 1994-05-24 | Paulos Manley A | Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor |
PT969821E (pt) * | 1997-03-26 | 2003-10-31 | Janssen Pharmaceutica Nv | Pastilhas tendo um nucleo revestido com um antifungico e um polimero |
SE9702533D0 (sv) | 1997-07-01 | 1997-07-01 | Astra Ab | New oral formulation |
US5895663A (en) * | 1997-07-31 | 1999-04-20 | L. Perrigo Company | Pseudoephedrine hydrochloride extended-release tablets |
US6050796A (en) | 1998-05-18 | 2000-04-18 | General Motors Corporation | Vane pump |
WO2001058424A1 (en) | 2000-02-09 | 2001-08-16 | West Pharmaceutical Services Drug Delivery & Clinical Research Centre Limited | Floating drug delivery composition |
JP2002370970A (ja) * | 2001-06-12 | 2002-12-24 | Sanwa Kagaku Kenkyusho Co Ltd | 胃内浮遊型固形製剤及びその製造方法 |
WO2003005951A2 (en) * | 2001-07-10 | 2003-01-23 | Teva Pharmaceutical Industries Ltd. | Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery |
US7763663B2 (en) * | 2001-12-19 | 2010-07-27 | University Of Massachusetts | Polysaccharide-containing block copolymer particles and uses thereof |
EP1574534A1 (en) * | 2004-03-11 | 2005-09-14 | Rohm And Haas Company | Polymer carriers and process |
-
2007
- 2007-09-03 EP EP07866696A patent/EP2068844A4/en not_active Withdrawn
- 2007-09-03 BR BRPI0716481-5A2A patent/BRPI0716481A2/pt not_active IP Right Cessation
- 2007-09-03 US US12/439,775 patent/US8277843B2/en not_active Expired - Fee Related
- 2007-09-03 AU AU2007323018A patent/AU2007323018B2/en not_active Ceased
- 2007-09-03 WO PCT/IN2007/000392 patent/WO2008062440A2/en active Application Filing
- 2007-09-03 JP JP2009526263A patent/JP2010502591A/ja active Pending
- 2007-09-03 CA CA002661172A patent/CA2661172A1/en not_active Abandoned
- 2007-09-03 ZA ZA200901162A patent/ZA200901162B/xx unknown
- 2007-09-03 KR KR1020097006969A patent/KR20090065524A/ko not_active Application Discontinuation
- 2007-09-03 CN CN200780032818XA patent/CN101511346B/zh not_active Expired - Fee Related
- 2007-09-03 RU RU2009112396/15A patent/RU2420268C2/ru not_active IP Right Cessation
- 2007-09-03 MX MX2009002371A patent/MX2009002371A/es unknown
- 2007-09-04 AR ARP070103903A patent/AR062644A1/es not_active Application Discontinuation
- 2007-09-04 CL CL200702562A patent/CL2007002562A1/es unknown
-
2009
- 2009-02-19 NO NO20090807A patent/NO20090807A/no not_active Application Discontinuation
- 2009-02-19 IL IL197121A patent/IL197121A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU2007323018A1 (en) | 2008-05-29 |
EP2068844A4 (en) | 2013-01-23 |
CA2661172A1 (en) | 2008-05-29 |
RU2009112396A (ru) | 2010-10-20 |
KR20090065524A (ko) | 2009-06-22 |
WO2008062440A2 (en) | 2008-05-29 |
BRPI0716481A2 (pt) | 2014-03-18 |
US20100015224A1 (en) | 2010-01-21 |
CN101511346A (zh) | 2009-08-19 |
IL197121A0 (en) | 2009-11-18 |
AU2007323018B2 (en) | 2011-02-03 |
RU2420268C2 (ru) | 2011-06-10 |
US8277843B2 (en) | 2012-10-02 |
MX2009002371A (es) | 2009-03-12 |
CN101511346B (zh) | 2012-07-04 |
EP2068844A2 (en) | 2009-06-17 |
CL2007002562A1 (es) | 2008-02-08 |
NO20090807A (no) | 2009-06-04 |
ZA200901162B (en) | 2010-06-30 |
WO2008062440A3 (en) | 2008-07-31 |
JP2010502591A (ja) | 2010-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR062644A1 (es) | Tecnologia de suministro programable flotante | |
AR062321A1 (es) | Sistema de liberacion controlada y metodo para fabricarlo | |
MY150626A (en) | Fast dissolving solid dosage form | |
CL2008000219A1 (es) | Composicion farmaceutica de liberacion modificada que comprende a uno o mas ingredientes farmaceuticamente activos, con solubilidad dependiente del ph, un polimero controlador de la liberacion, agentes facilitadores de la gelificacion; procedimiento | |
CL2007003193A1 (es) | Metodo para evitar o reducir la vasoconstriccion a continuacion de la administracion de un portador de oxigeno vasoactivo, que comprende oxido nitrico gaseoso y otro agente activo; composicion farmaceutica que comprende un inhibidor de fosfodiesteras | |
AR078417A1 (es) | Composiciones de pelicula sublingual y bucal | |
CL2011000170A1 (es) | Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa. | |
PE20140255A1 (es) | Tableta dispersable en forma oral | |
JP2014515038A5 (es) | ||
SMT201200014B (it) | Nalmefene cloridrato diidrato. | |
CL2011002968A1 (es) | Forma de dosificacion de extrusion por fusion caliente de un ingrediente activo (a) incluido en una matriz que comprende un polimero (c), que el nucleo presenta una orientacion morfologica ortogonal respecto a la direccion longitudinal de extension de la forma de dosificacion; y su procedimiento de preparacion. | |
PE20070618A1 (es) | Composicion farmaceutica que contiene rosiglitazona en el tratamiento de alzheimer | |
BR112012015749A2 (pt) | processos para produção de um agente farmaceuticamente ativo | |
CL2007003331A1 (es) | Metodo para tratar cancer mediante la administracion de un agente radiosensibilizante derivado de benzo[a]trinden-4,6-diona; composicion farmaceutica que comprende dicho agente. | |
BRPI0822885A2 (pt) | Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral | |
ECSP10010514A (es) | Formulaciones mejoradas para ingredientes farmaceuticos activos de permeabilidad deficiente | |
NI201100025A (es) | Métodos de administración de las formulaciones tópicas antimicóticas para el tratamiento de las infecciones por hongos. | |
CR20110267A (es) | Tratamiento de transtornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il) benzo[]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma | |
CL2015000375A1 (es) | Composicion farmaceutica en forma de microparticulas que comprende un nucleo inerte y al menos una primera capa de principio activo; proceso de formacion de microparticulas; combinacion farmaceutica; kit farmaceutico; uso para tratar y/o prevenir edemas, enfermedades cardiovasculares, diabetes, hipertension, entre otras. | |
MX2008008413A (es) | Composicion farmaceutica para el tratamiento de las enfermedades de las uñas. | |
AR081520A1 (es) | Composicion farmaceutica que comprende una dispersion solida de tacrolimus en un vehiculo | |
MY191875A (en) | Solid dosage form | |
PE20150773A1 (es) | Composiciones farmaceuticas para la liberacion sostenida de fenilefrina | |
CL2012003341A1 (es) | Composicion farmaceutica de administracion oral que compende bendamustina o un ester, una sal o un solvato de la misma, y un excipiente que es un agente tensioactivo no ionico e hidrofilico; combinacion farmaceutica; y su uso para el tratamiento de leucemia linfocitica cronica y el mieloma multiple, entre otras enfermedades. | |
DE502008002255D1 (de) | Arzneimittel enthaltend Fraumenmantel zur Behandlung von Endometritis, Vaginitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |